Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
07/2003
07/31/2003WO2003016338A9 Crystal structure of the btk kinase domain
07/31/2003WO2003016333A3 Virus coat protein/receptor chimeras and methods of use
07/31/2003WO2003014879A3 System and method for identifying a genetic risk factor for a disease or pathology
07/31/2003WO2003014138A8 Method for immobilizing compounds by means of nitron formation and arrangement for immobilizing compounds
07/31/2003WO2003011118A3 Human zona pellucida proteins and methods of their use in diagnosing male infertility
07/31/2003WO2003008630A3 Methods of profiling gene expression, protein or metabolite levels
07/31/2003WO2003008578A3 Reagents and methods for identifying gene targets for treating cancer
07/31/2003WO2003006499A3 Survivin interacting protein tpr1
07/31/2003WO2003004607A3 Aggrecanase molecules
07/31/2003WO2003001891A3 Method and apparatus for computer modeling of an adaptive immune response
07/31/2003WO2003000024A3 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection
07/31/2003WO2002103320A3 Diagnosis and prognosis of breast cancer patients
07/31/2003WO2002101005A3 A g-protein coupled receptor and uses therefor
07/31/2003WO2002100408A3 Treating neuropathic/inflammatory pain by targeting a composition (e.g. zd7288) to hcn pacemaker channels
07/31/2003WO2002099434A3 Use of 14-3-3 proteins and a method for determining the same in the fluids or tissues of organisms
07/31/2003WO2002099042A3 Cads as modifiers of the p53 pathway and methods of use
07/31/2003WO2002097443A3 Method for diagnosing transmissable spongiform encephalopathy
07/31/2003WO2002086123A3 A human g-protein coupled receptor, hgprbmy11, expressed highly in heart and variants thereof
07/31/2003WO2002084293A3 Multiple analyte assaying device with a multiple sample introduction system
07/31/2003WO2002083848A3 Methods and apparatus for selectively processing eggs having identified characteristics
07/31/2003WO2002072886A3 Complex element micro-array and methods of use
07/31/2003WO2002068947A3 Infrared thermographic screening technique for semiconductor-based chemical sensors
07/31/2003WO2002063000A3 Purified and isolated platelet calcium channel nucleic acids and polypeptides and therapeutic and screening methods using same
07/31/2003WO2002060464A3 Compositions containing an active fraction isolated from hedyotis diffusae and methods of use
07/31/2003WO2002059148A3 A method for identification, isolation and production of antigens to a specific pathogen
07/31/2003WO2002052276A9 Protein s functional assay
07/31/2003WO2002042498A3 Dual bead assays including optical biodiscs and methods relating thereto
07/31/2003WO2002039885A3 Compositions and methods for the therapy and diagnosis of ovarian cancer
07/31/2003WO2002029038A3 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
07/31/2003WO2002024909A3 Receptor nucleic acids and polypeptides
07/31/2003WO2002024747A3 Polymorphisms in human genes of cardiovascular regulators and their use in diagnostic and therapeutic applications
07/31/2003WO2002020847A3 Gene and sequence variation associated with lipid disorder
07/31/2003WO2002018956A3 Apparatus and methods for analysing samples
07/31/2003WO2002018659A3 Method for determining alleles
07/31/2003WO2002018444A3 Erbb4 antagonists
07/31/2003WO2002015895A3 Alpha-difluoromethylornithine (dfmo) use in the human prostate
07/31/2003WO2002012892A3 Rapid multiple panel of biomarkers in laboratory blood tests for tia/stroke
07/31/2003WO2002010450A3 Replicable probe array
07/31/2003WO2002008949A3 Methods and systems for evaluating a matching between measured data and standards
07/31/2003WO2002004489A3 Polymorphic kinase anchor proteins and nucleic acids encoding the same
07/31/2003WO2001096870A3 Immunoassays for anti-hcv antibodies
07/31/2003WO2001096857A3 Method and apparatus for combined magnetophoretic and dielectrophoretic manipulation of analyte mixtures
07/31/2003WO2001094634A3 Methods and devices for multiplexing amplification reactions
07/31/2003WO2001092990A3 Structure-based methods for assessing amino acid variances
07/31/2003WO2001085912A3 Presenilin enhancers
07/31/2003WO2001067369A3 Combinatorial array for nucleic acid analysis
07/31/2003US20030144883 Method for analyzing side effects and interactions of pharmaceuticals
07/31/2003US20030144823 Scale-free network inference methods
07/31/2003US20030144581 Devices and methods for frequent measurement of an analyte present in a biological system
07/31/2003US20030144499 Photocleavable protecting groups and methods for their use
07/31/2003US20030144492 Anticancer agents; central nervous system disorders; antiinflammatory agents
07/31/2003US20030144482 Diagnosis of skin cancer; vaccine
07/31/2003US20030144480 Genetic engineering; medical diagnosis
07/31/2003US20030144473 Peptides for the production of preparations for the diagnosis and therapy of autoimmun diseases
07/31/2003US20030144472 Method of identifying designable protein backbone configurations
07/31/2003US20030144340 By inhibiting fetal cardiac gene expression and interfering with sarcomeric organization
07/31/2003US20030144336 Method of selecting nonsedating H1-antagonists
07/31/2003US20030144297 Substituted aryl 1,4-pyrazine derivatives
07/31/2003US20030144266 Pyrazolo-triazolo- pyrimidine, triazolo-triazolo-pyrimidine and imidazolo-triazolo-pyrimidine derivatives useful for the treatment of hypertension, inflammation, mast cell degranulation, cardiac hypoxia, and ischemia
07/31/2003US20030144239 Expression system
07/31/2003US20030144237 Antagonist for synergistic treatment of a thromboembolic disease
07/31/2003US20030144233 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides
07/31/2003US20030144232 Expression system
07/31/2003US20030144199 Modified ciliary neurotrophic factor, method of making and methods of use thereof
07/31/2003US20030144194 Cancer treatment and prognosis
07/31/2003US20030144192 Crystal proteins which exhibit insecticidal activity against coleopteran insects including red flour beetle larvae (Tribolium castaneum) and Japanese beetle larvae (Popillia japonica)
07/31/2003US20030144190 Apoptosis modulation in fast growing cells and induction and/or stimulation of proapoptotic pathway in fast growing cells, especially in Ras-induced malignancies
07/31/2003US20030144188 Androgen regulated nucleic acid molecules and encoded proteins
07/31/2003US20030144177 Contacting cell indicative of pathological condition from diseased individual and cell from genetically related normal individual with candidate therapeutic compounds, identifying compound that alters predetermined property of diseased cell
07/31/2003US20030144176 Methods and compositions relating to MEK5 and cardiac hypertrophy and dilated cardiomyopathy
07/31/2003US20030144069 Measurement of the Coefficient of Restitution of A Golf Club
07/31/2003US20030143759 Measuring in an assay containing the sample and a substrate for activated protein c, the conversion of the substrate by activated protein c and correlating to the functional activity
07/31/2003US20030143758 Insoluble carrier particle nephelometric immunoassay reagent
07/31/2003US20030143757 Methods for identifying drug cores
07/31/2003US20030143755 Assays
07/31/2003US20030143753 Analysis of antioxidant in solder plating solutions using molybdenum dichloride dioxide
07/31/2003US20030143750 Peptide compounds, method of measuring sulfur compound and ammonia therewith, and measuring device using the same
07/31/2003US20030143749 Milk sampling apparatus and method
07/31/2003US20030143748 Milk sampling apparatus and method
07/31/2003US20030143746 Self-calibrating body anayte monitoring system
07/31/2003US20030143735 Contacting human vpr interacting protein with a test compound and comparing the affinity of the vpr in the presence and absence of it
07/31/2003US20030143726 Biosensor involving the use of optically sensitive moieties
07/31/2003US20030143725 Microarray fabrication techniques and apparatus
07/31/2003US20030143720 High throughput functional genomics
07/31/2003US20030143690 Peptides and proteins that effect protein phosphorylation; genetic engineered DNA; useful for therapy and diagnosis
07/31/2003US20030143687 Biologic variability of asthma associated factors useful in treating and diagnosing atopic allergies including asthma and related disorders
07/31/2003US20030143684 Combining a compound to be tested, a host cell expressing a recombinant protein containing a mammalian C-C chemokine receptor 3 and a ligand for binding of ligand to such receptor, detecting the formation of a receptor-ligand complex
07/31/2003US20030143683 Introducing a nucleotide sequence encoding prefered amino acid sequences in into a host cell and culturing the host cell in which the peptides are expressed from the nucleotide sequence; human therapeutics and diagnostic protein
07/31/2003US20030143675 Novel 38594, 57312, 53659, 57250, 63760, 49938, 32146, 57259, 67118, 67067, 62092, 8099, 46455, 54414, 53763, 67076, 67102, 44181, 67084FL, 67084ALT, FBH58295FL, 57255, and 57255alt molecules and uses therefor
07/31/2003US20030143674 Polypeptides fused to heterologous polypeptide sequences, and an antibodies which bind to the above polypeptides
07/31/2003US20030143667 Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions
07/31/2003US20030143665 Calcium independent receptor of alpha-latrotoxin,characterization and uses thereof
07/31/2003US20030143658 Culturing then incubating with chromogen; antibiotic-free; for testing potable water
07/31/2003US20030143656 Drug screening compounds which inhibit rate of phosphorylation by kinase having hydrophobic pocket domain; surface plasmon resonance; fusion proteins; anticancer-/ antidiabetic agents
07/31/2003US20030143655 For competitive immunoassays for detection of lysergic acid (LAD) metabolite; drug screening; forensics
07/31/2003US20030143654 Which participates in the ubiquitin-dependent proteolytic pathway that targets regulatory proteins for rapid intracellular degradation
07/31/2003US20030143653 Method and kit for detecting, or determining the quantity of, beta-lactam penicillins
07/31/2003US20030143652 Kits detect antibodies with conjugated labels comprising protein A and/or colloidal gold; vaccines
07/31/2003US20030143651 Fret protease assays for clostridial toxins
07/31/2003US20030143650 Fret protease assays for botulinum serotype A/E toxins
1 ... 2540 2541 2542 2543 2544 2545 2546 2547 2548 2549 2550 2551 2552 2553 2554 2555 2556 2557 2558 2559 2560 ... 3937